Advanced
  Home Compare Reports

Comparison with Similar Reports

Medical Device Contract Manufacturing Market by Device Type (IVD (Equipment, Consumable), Cardiovascular, Diabetes Care, Drug Delivery, Orthopedic, Op...

Publisher:        MarketsandMarkets

# of Pages:        349

Rating: 

1 User License $4,950

Publication Date:  July, 2021

Price:       $4,950 / User License




1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 43
1.3 MARKET SCOPE 43
1.3.1 MARKETS COVERED 43
FIGURE 1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SEGMENTATION 43
FIGURE 2 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION 44
1.3.2 YEARS CONSIDERED FOR THE STUDY 44
1.4 CURRENCY 44
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 45
1.5 STAKEHOLDERS 45
1.6 SUMMARY OF CHANGES 45
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DATA 47
FIGURE 3 RESEARCH DESIGN 47
2.1.1 SECONDARY DATA 48
2.1.1.1 Key data from secondary sources 49
2.1.2 PRIMARY DATA 50
FIGURE 4 PRIMARY SOURCES 50
2.1.2.1 Key data from primary sources 51
2.1.2.2 Key industry insights 51
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 52
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 52
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 53
2.2 MARKET SIZE ESTIMATION 53
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 54
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: FLEX, LTD. 54
FIGURE 10 SUPPLY-SIDE ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2020) 55
FIGURE 11 DEMAND-SIDE ESTIMATION FOR THE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 56
FIGURE 12 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2021–2026) 57
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 57
FIGURE 14 TOP-DOWN APPROACH 58
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 59
FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY 59
2.4 MARKET SHARE ESTIMATION 59
2.5 ASSUMPTIONS FOR THE STUDY 60
2.6 LIMITATIONS 60
2.6.1 METHODOLOGY-RELATED LIMITATIONS 60
2.7 RISK ASSESSMENT 61
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 61
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 61
3 EXECUTIVE SUMMARY 62
FIGURE 16 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021 VS. 2026 (USD MILLION) 62
FIGURE 17 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2021 VS. 2026 (USD MILLION) 63
FIGURE 18 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE,
2019 VS. 2026 (USD MILLION) 63
FIGURE 19 GEOGRAPHICAL SNAPSHOT OF THE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 64
4 PREMIUM INSIGHTS 65
4.1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET OVERVIEW 65
FIGURE 20 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICE MODALITIES TO DRIVE MARKET GROWTH 65
4.2 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEVELOPED VS. DEVELOPING MARKETS 66
FIGURE 21 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 66
4.3 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 67
FIGURE 22 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 67
4.4 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGIONAL MIX 68
FIGURE 23 ASIA PACIFIC REGION WILL CONTINUE TO DOMINATE THE MARKET IN 2026 68
5 MARKET OVERVIEW 69
5.1 INTRODUCTION 69
TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS 69
5.2 MARKET DRIVERS 70
5.2.1 GROWTH IN THE MEDICAL DEVICES MARKET 70
FIGURE 24 ASIA PACIFIC: GDP GROWTH RATE, 2018 VS. 2023 (FORECAST) 70
FIGURE 25 GROWTH OF THE GLOBAL GDP FROM 2015 TO 2026 (COMPARED TO THE PREVIOUS YEAR) 70
5.2.2 ADOPTION OF ROBOTICS AND AUTOMATION 71
5.2.3 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICE MODALITIES 71
FIGURE 26 FACTORS DRIVING THE DEMAND FOR CONTRACT MANUFACTURING 72
5.2.4 IMPACT OF INDUSTRY 4.0 ON THE MEDICAL DEVICE INDUSTRY 72
5.3 MARKET RESTRAINTS 73
5.3.1 CONSOLIDATION IN THE MEDICAL DEVICES MARKET 73
TABLE 4 KEY ACQUISITIONS IN THE MEDICAL DEVICE INDUSTRY 73
5.4 MARKET OPPORTUNITIES 74
5.4.1 GROWING HEALTHCARE EXPENDITURE 74
TABLE 5 HEALTHCARE EXPENDITURE (%), BY COUNTRY (2010 VS. 2015 VS. 2019) 74
FIGURE 27 ASIA PACIFIC: HEALTHCARE EXPENDITURE PER CAPITA (USD) (2002 VS. 2010 VS. 2018) 75
5.4.2 RISING GERIATRIC POPULATION 75
TABLE 6 ESTIMATED INCREASE IN THE GERIATRIC POPULATION, BY REGION,
2019 VS. 2050 75
TABLE 7 AVERAGE LIFE EXPECTANCY, 2023 (FORECAST) 76
5.5 MARKET CHALLENGES 76
5.5.1 BALANCING TECHNOLOGICAL CAPABILITIES AGAINST COSTS 76
5.6 PORTER’S FIVE FORCES ANALYSIS 77
FIGURE 28 PORTER’S FIVE FORCES ANALYSIS (2020): MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 77
TABLE 8 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 77
5.6.1 THREAT OF NEW ENTRANTS 78
5.6.1.1 Growth in the overall medical device industry 78
5.6.1.2 Demand for compact, cost-effective, and non-invasive devices 78
5.6.1.3 Consolidation 78
5.6.1.4 Poor financing environment 78
5.6.1.5 Proficient management teams 78
5.6.1.6 Stringent regulatory environment 78
5.6.2 THREAT OF SUBSTITUTES 79
5.6.2.1 Undesirability of existing portfolios 79
5.6.2.2 Combination and integration of multiple technologies 79
5.6.2.3 Availability of alternatives 79
5.6.3 BARGAINING POWER OF SUPPLIERS 79
5.6.3.1 Big medical device contract manufacturing companies 79
5.6.3.2 Institutional technology providers 79
5.6.3.3 Substantially innovative technologies 79
5.6.3.4 Dysfunctional companies 80
5.6.3.5 Academic inventors 80
5.6.4 BARGAINING POWER OF BUYERS 80
5.6.4.1 Few buyers and many sellers 80
5.6.4.2 Buy-out threat 80
5.6.4.3 Demand for new pipeline services 80
5.6.4.4 Point of differentiation 80
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 81
5.6.5.1 Similar spectrum of services offered 81
5.6.5.2 Similar funding source 81
5.6.5.3 Self-funded big contract manufacturers 81
5.6.5.4 Highly fragmented industry 81
5.7 REGULATORY ANALYSIS 81
5.7.1 NORTH AMERICA 81
5.7.1.1 US 81
TABLE 9 US: CLASSIFICATION OF MEDICAL EQUIPMENT 81
TABLE 10 US: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 82
5.7.1.2 Canada 82
TABLE 11 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 82
5.7.2 EUROPE 83
TABLE 12 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 83
5.7.3 ASIA PACIFIC 83
5.7.3.1 Japan 83
TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 84
5.7.3.2 China 84
TABLE 14 CHINA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 85
5.7.3.3 India 85
5.8 SUPPLY CHAIN ANALYSIS 85
FIGURE 29 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2020) 86
5.9 ECOSYSTEM MAPPING 86
FIGURE 30 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: ECOSYSTEM (2020) 86
FIGURE 31 COVID IMPACT ON THE IVD ECOSYSTEM, 2020 87
5.10 KEY MARKETS FOR IMPORT AND EXPORT (TRADE ANALYSIS FOR MEDICAL DEVICES) 87
TABLE 15 IMPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2018 87
FIGURE 32 VALUE OF MEDICAL EQUIPMENT EXPORTS FROM CHINA,
2008–2019 (USD BILLION) 88
5.11 COVID-19 IMPACT ON THE MEDICAL DEVICE CONTRACT MANUFACTURING INDUSTRY 88
5.12 YC-YCC SHIFT: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 89
FIGURE 33 YC-YCC SHIFT IN THE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 89
5.13 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 90
FIGURE 34 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 90
5.14 INDUSTRY TRENDS 90
5.14.1 INCREASING CONSOLIDATION OF ORIGINAL EQUIPMENT MANUFACTURERS AND CONTRACT MANUFACTURING ORGANIZATIONS 90
TABLE 16 KEY EXAMPLES OF OEM CONSOLIDATION IN THE LAST 5 YEARS 91
TABLE 17 KEY EXAMPLES OF CMO CONSOLIDATION 91
5.14.2 GROWING INTEREST OF PRIVATE EQUITY FIRMS IN MEDICAL DEVICE CONTRACT MANUFACTURING 92
TABLE 18 KEY INVESTMENTS BY PRIVATE EQUITY FIRMS 92
5.14.3 OUTSOURCING OF MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES 93
TABLE 19 EXAMPLES OF KEY COLLABORATIONS AND AGREEMENTS 93
6 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE 94
6.1 INTRODUCTION 95
TABLE 20 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2019–2026 (USD MILLION) 95
6.2 IVD DEVICES 96
TABLE 21 IVD DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 96
TABLE 22 IVD DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 97
6.2.1 IVD CONSUMABLES 97
6.2.1.1 Increasing demand for reagents & kits and growing focus on COVID-19 screening to drive the growth of this market segment 97
TABLE 23 IVD CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 98
6.2.2 IVD EQUIPMENT 98
6.2.2.1 Advances in life sciences research to support market growth 98
TABLE 24 IVD EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 99
6.3 DIAGNOSTIC IMAGING DEVICES 99
6.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH 99
TABLE 25 DIAGNOSTIC IMAGING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 100
6.4 CARDIOVASCULAR DEVICES 101
6.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 101
TABLE 26 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015–2035 101
TABLE 27 CARDIOVASCULAR DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 102
6.5 DRUG DELIVERY DEVICES 102
TABLE 28 DRUG DELIVERY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 103
TABLE 29 DRUG DELIVERY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 103
6.5.1 INFUSION DEVICES AND ADMINISTRATION SETS 104
6.5.1.1 Rising incidence of chronic diseases and the growing number of surgical procedures to drive market growth 104
TABLE 30 INFUSION DEVICES AND ADMINISTRATION SETS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
6.5.2 SYRINGES 105
6.5.2.1 High cost of safety syringes and the increasing incidence of needlestick injuries are the major challenges faced by manufacturers 105
TABLE 31 SYRINGES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
6.5.3 INHALERS 107
6.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to drive market growth 107
TABLE 32 INHALERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 107
6.5.4 AUTOINJECTORS & PEN INJECTORS 108
6.5.4.1 Rising number of regulatory approvals for new drug therapies and advancements in drug delivery are supporting market growth 108
TABLE 33 RECENT APPROVALS FOR AUTOINJECTORS & PEN INJECTORS ACROSS THE GLOBE 108
TABLE 34 AUTOINJECTORS AND PEN INJECTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 109
6.6 ORTHOPEDIC DEVICES 109
6.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE THE GROWTH OF THIS MARKET 109
TABLE 35 ORTHOPEDIC DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 110
6.7 RESPIRATORY CARE DEVICES 111
6.7.1 COVID-19 TO BOOST THE DEMAND FOR THE CONTRACT MANUFACTURING OF RESPIRATORY CARE DEVICES 111
TABLE 36 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 111
6.8 OPHTHALMOLOGY DEVICES 112
6.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET GROWTH 112
TABLE 37 OPHTHALMOLOGY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 113
6.9 SURGICAL DEVICES 113
6.9.1 INCREASE IN THE NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH 113
TABLE 38 SURGICAL DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
6.10 DIABETES CARE DEVICES 114
6.10.1 RISING PREVALENCE OF DIABETES IS DRIVING THE DEMAND FOR DIABETES DEVICES AND CONSUMABLES 114
TABLE 39 DIABETES CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 115
6.11 DENTAL DEVICES 116
6.11.1 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET GROWTH 116
TABLE 40 DENTAL DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 117
6.12 ENDOSCOPY DEVICES 117
6.12.1 GROWTH IN THIS MARKET IS DRIVEN BY THE RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES 117
TABLE 41 ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 118
6.13 GYNECOLOGY/UROLOGY DEVICES 119
6.13.1 GROWING AWARENESS AND PREVENTIVE CHECK-UPS FOR THE LATE-PHASE DIAGNOSIS OF STDS WILL PROPEL MARKET GROWTH 119
TABLE 42 GYNECOLOGY/UROLOGY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 119
6.14 PERSONAL CARE DEVICES 120
6.14.1 SHIFT IN THE CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO DRIVE MARKET GROWTH 120
TABLE 43 PERSONAL CARE DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 120
6.15 NEUROLOGY DEVICES 121
6.15.1 RISING GLOBAL BURDEN OF NEUROLOGICAL DISEASES WILL DRIVE MARKET GROWTH 121
TABLE 44 NEUROLOGY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
6.16 OTHER DEVICES 122
TABLE 45 CONTRACT MANUFACTURING MARKET FOR OTHER DEVICES, BY COUNTRY, 2019–2026 (USD MILLION) 123
7 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE 124
7.1 INTRODUCTION 125
TABLE 46 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 125
7.2 COMPARISON OF DEVICE CLASSIFICATION BY COUNTRY/REGION 125
7.2.1 US 125
7.2.1.1 Class I: General controls 125
7.2.1.2 Class II: General controls with special controls 126
7.2.1.3 Class III: General controls, special controls, and premarket approval 126
7.2.2 CANADA 126
7.2.3 EUROPEAN UNION AND EUROPEAN FREE TRADE ASSOCIATION 126
7.2.3.1 Class I Medical Devices 126
7.2.3.1.1 Class Is: Non-invasive devices 126
7.2.3.1.2 Class Im: Low-risk measuring devices 126
7.2.3.2 Class IIa Medical Devices 127
7.2.3.3 Class IIb Medical Devices 127
7.2.3.4 Class III Medical Devices 127
7.2.4 ASIA PACIFIC 127
7.2.4.1 China 127
7.2.4.2 India 127
7.2.4.3 Japan 127
7.2.4.4 Australia 128
7.3 CLASS II MEDICAL DEVICES 128
7.3.1 HIGH-VOLUME UTILIZATION OF THESE DEVICES BY END USERS TO SUPPORT MARKET GROWTH 128
TABLE 47 CLASS II MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 129
7.4 CLASS I MEDICAL DEVICES 129
7.4.1 CLASS I MEDICAL DEVICES HAVE MINIMUM POTENTIAL TO HARM USERS 129
TABLE 48 CLASS I MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 130
7.5 CLASS III MEDICAL DEVICES 130
7.5.1 THESE DEVICES INVOLVE THE HIGHEST LEVEL OF ASSOCIATED HEALTH RISKS TO PATIENTS AND USERS 130
TABLE 49 CLASS III MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 131
8 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE 132
8.1 INTRODUCTION 133
FIGURE 35 STAGES INVOLVED IN THE CONTRACT MANUFACTURING OF MEDICAL DEVICES 133
TABLE 50 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE,
2019–2026 (USD MILLION) 133
8.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES 134
TABLE 51 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 52 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 134
8.2.1 DEVICE MANUFACTURING SERVICES 135
8.2.1.1 Device manufacturing services is the largest and fastest-growing segment of the device development and manufacturing services market 135
TABLE 53 DEVICE MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 136
8.2.2 PROCESS DEVELOPMENT SERVICES 136
8.2.2.1 Transition from conventional contract manufacturing to automated contract manufacturing & testing to drive the growth of this segment 136
FIGURE 36 DEVICE PROCESS DEVELOPMENT SERVICES 137
TABLE 54 PROCESS DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 138
8.2.3 DEVICE ENGINEERING SERVICES 138
8.2.3.1 The complexity of device engineering services to support market growth 138
TABLE 55 DEVICE ENGINEERING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 139
8.3 QUALITY MANAGEMENT SERVICES 140
TABLE 56 QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 57 QUALITY MANAGEMENT SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
8.3.1 PACKAGING VALIDATION SERVICES 141
8.3.1.1 Increasing product safety concerns for medical devices is a key factor driving the market growth 141
TABLE 58 PACKAGING VALIDATION SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 142
8.3.2 INSPECTION AND TESTING SERVICES 142
8.3.2.1 These services offer the expertise and technology to help eliminate the need for large capital & overhead investments 142
TABLE 59 INSPECTION AND TESTING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 143
8.3.3 STERILIZATION SERVICES 143
8.3.3.1 The rising complexity of sterility standards to drive market growth 143
TABLE 60 STERILIZATION SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 144
8.4 PACKAGING AND ASSEMBLY SERVICES 144
FIGURE 37 FINAL ASSEMBLY SERVICES IN THE GLOBAL VALUE CHAIN OF MEDICAL DEVICES 145
TABLE 61 PACKAGING AND ASSEMBLY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 62 PACKAGING AND ASSEMBLY SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 146
8.4.1 PRIMARY AND SECONDARY PACKAGING SERVICES 146
8.4.1.1 Growth in the primary and secondary packaging segment is driven
by growing concerns for patient safety 146
TABLE 63 PRIMARY AND SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 147
8.4.2 LABELING SERVICES 147
8.4.2.1 Export bans and product recalls due to improper labeling to support market growth 147
TABLE 64 LABELING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 148
8.4.3 OTHER PACKAGING AND ASSEMBLY SERVICES 148
TABLE 65 OTHER PACKAGING AND ASSEMBLY SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 149
8.5 OTHER SERVICES 149
TABLE 66 OTHER SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 150
9 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION 151
9.1 INTRODUCTION 152
FIGURE 38 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 152
TABLE 67 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION,
2019–2026 (USD MILLION) 153
9.2 ASIA PACIFIC 153
FIGURE 39 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SNAPSHOT 154
TABLE 68 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 155
TABLE 69 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY DEVICE TYPE, 2019–2026 (USD MILLION) 155
TABLE 70 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 71 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 72 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 156
TABLE 73 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2019–2026 (USD MILLION) 157
TABLE 74 ASIA PACIFIC: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 75 ASIA PACIFIC: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 76 ASIA PACIFIC: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
9.2.1 CHINA 158
9.2.1.1 Medical device contract manufacturing market in China is mainly driven by low labor costs 158
TABLE 77 CHINA: KEY MACROINDICATORS 159
TABLE 78 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY DEVICE TYPE, 2019–2026 (USD MILLION) 159
TABLE 79 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 80 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 81 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 160
TABLE 82 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2019–2026 (USD MILLION) 161
TABLE 83 CHINA: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 84 CHINA: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 85 CHINA: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
9.2.2 JAPAN 162
9.2.2.1 Presence of key players in the country to drive market growth 162
TABLE 86 JAPAN: KEY MACROINDICATORS 162
TABLE 87 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY DEVICE TYPE, 2019–2026 (USD MILLION) 163
TABLE 88 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 89 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 90 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 164
TABLE 91 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019–2026 (USD MILLION) 164
TABLE 92 JAPAN: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 93 JAPAN: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 94 JAPAN: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
9.2.3 MALAYSIA & SINGAPORE 166
9.2.3.1 Increasing R&D activities and investments by established players to drive market growth 166
TABLE 95 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2019–2026 (USD MILLION) 167
TABLE 96 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 97 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 98 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 168
TABLE 99 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019–2026 (USD MILLION) 168
TABLE 100 MALAYSIA & SINGAPORE: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 169
TABLE 101 MALAYSIA & SINGAPORE: QUALITY MANAGEMENT SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 169
TABLE 102 MALAYSIA & SINGAPORE: PACKAGING & ASSEMBLY SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 169
9.2.4 INDIA 170
9.2.4.1 Rising contract manufacturing capabilities in the country to support market growth 170
TABLE 103 INDIA: KEY MACROINDICATORS 170
TABLE 104 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY DEVICE TYPE, 2019–2026 (USD MILLION) 171
TABLE 105 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 106 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 172
TABLE 107 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 172
TABLE 108 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019–2026 (USD MILLION) 172
TABLE 109 INDIA: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 110 INDIA: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 111 INDIA: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
9.2.5 AUSTRALIA & NEW ZEALAND 174
9.2.5.1 Need for advanced medical and diagnostic tools to drive market growth in Australia and New Zealand 174
TABLE 112 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2019–2026 (USD MILLION) 174
TABLE 113 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 114 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 115 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 175
TABLE 116 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019–2026 (USD MILLION) 176
TABLE 117 AUSTRALIA & NEW ZEALAND: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 118 AUSTRALIA & NEW ZEALAND: QUALITY MANAGEMENT SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 119 AUSTRALIA & NEW ZEALAND: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 177
9.2.6 SOUTH KOREA 177
9.2.6.1 High-value imports from other countries to offer growth opportunities for contract manufacturers in the country 177
TABLE 120 SOUTH KOREA: MEDICAL DEVICES MARKET (USD BILLION) 177
TABLE 121 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY DEVICE TYPE, 2019–2026 (USD MILLION) 178
TABLE 122 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 123 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 124 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 179
TABLE 125 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2019–2026 (USD MILLION) 179
TABLE 126 SOUTH KOREA: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 127 SOUTH KOREA: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 128 SOUTH KOREA: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 180
9.2.7 REST OF ASIA PACIFIC 181
TABLE 129 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2019–2026 (USD MILLION) 181
TABLE 130 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 131 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE,
2019–2026 (USD MILLION) 182
TABLE 132 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 182
TABLE 133 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019–2026 (USD MILLION) 182
TABLE 134 REST OF ASIA PACIFIC: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 135 REST OF ASIA PACIFIC: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 136 REST OF ASIA PACIFIC: PACKAGING & ASSEMBLY SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 183
 
9.3 NORTH AMERICA 184
TABLE 137 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 184
TABLE 138 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2019–2026 (USD MILLION) 184
TABLE 139 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 140 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 141 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 185
TABLE 142 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019–2026 (USD MILLION) 186
TABLE 143 NORTH AMERICA: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 144 NORTH AMERICA: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 145 NORTH AMERICA: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 187
9.3.1 US 187
9.3.1.1 Increasing cost of in-house manufacturing is encouraging medical device companies to adopt contract manufacturing as a cost-cutting measure 187
TABLE 146 US: KEY MACROINDICATORS 188
TABLE 147 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY DEVICE TYPE, 2019–2026 (USD MILLION) 188
TABLE 148 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 149 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 150 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 189
TABLE 151 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2019–2026 (USD MILLION) 190
TABLE 152 US: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 153 US: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 154 US: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
9.3.2 CANADA 191
9.3.2.1 Strong presence of key contract manufacturing companies in the country to support market growth 191
TABLE 155 CANADA: KEY MACROINDICATORS 192
TABLE 156 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY DEVICE TYPE, 2019–2026 (USD MILLION) 192
TABLE 157 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 158 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 159 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 193
TABLE 160 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2019–2026 (USD MILLION) 194
TABLE 161 CANADA: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 162 CANADA: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 163 CANADA: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
9.4 EUROPE 195
TABLE 164 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 196
TABLE 165 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2019–2026 (USD MILLION) 196
TABLE 166 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 167 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 168 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 197
TABLE 169 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2019–2026 (USD MILLION) 198
TABLE 170 EUROPE: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 171 EUROPE: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 172 EUROPE: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
9.4.1 GERMANY 199
9.4.1.1 Germany holds the largest market share due to the presence of major device manufacturers and high healthcare expenditure 199
TABLE 173 GERMANY: KEY MACROINDICATORS 199
TABLE 174 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY DEVICE TYPE, 2019–2026 (USD MILLION) 200
TABLE 175 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 176 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 177 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 201
TABLE 178 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2019–2026 (USD MILLION) 201
TABLE 179 GERMANY: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 202
TABLE 180 GERMANY: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 181 GERMANY: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
9.4.2 FRANCE 203
9.4.2.1 Increasing government pressure to reduce healthcare costs and budgetary constraints to support the contract manufacturing market 203
TABLE 182 FRANCE: KEY MACROINDICATORS 203
TABLE 183 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY DEVICE TYPE, 2019–2026 (USD MILLION) 204
TABLE 184 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 185 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 186 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE, 2019–2026 (USD MILLION) 205
TABLE 187 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2019–2026 (USD MILLION) 205
TABLE 188 FRANCE: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 189 FRANCE: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 190 FRANCE: PACKAGING & ASSEMBLY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 206

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127